Nuclear neuroimaging in acute and subacute ischemic stroke

Annals of Nuclear Medicine

Volumn 24, Issue 9, 2010, Pages 629-638

  Oku, Naohiko ^a   Kashiwagi, Toru ^a   Hatazawa, Jun ^b  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Neuroimaging; Penumbra; PET; SPECT; Stroke

Indexed keywords

ANIMAL; BRAIN; BRAIN ISCHEMIA; DIAGNOSTIC IMAGING; HEMODYNAMICS; HUMAN; METABOLISM; METHODOLOGY; NUCLEAR MEDICINE; PATHOPHYSIOLOGY; RADIOGRAPHY; REVIEW; SCINTISCANNING; STROKE;

ANIMALS; BRAIN; BRAIN ISCHEMIA; DIAGNOSTIC IMAGING; HEMODYNAMICS; HUMANS; NUCLEAR MEDICINE; STROKE;

EID: 79953236036     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-010-0421-7     Document Type: Review

References (105)

1. Friedman PJ, Davis G, Allen B. Semi-quantitative SPECT scanning in acute ischaemic stroke. Scand J Rehabil Med. 1993;25:99-105. (Pubitemid 23303945)
2. 99mTc-ethylcysteinate dimer brain SPECT patterns in the acute phase of stroke as predictors of neurological recovery. Cerebrovasc Dis. 2000;10:364-73.
3. Alexandrov AV, Ehrlich LE, Bladin CF, Norris JW. Noninvasive assessment of intracranial perfusion in acute cerebral ischemia. J Neuroimaging. 1995;5:76-82.
4. Giubilei F, Lenzi GL, Di Pielo V, Pozzilli C, Pantano P, Bastianello S, et al. Predictive value of brain perfusion single-photon emission computed tomography in acute ischemic stroke. Stroke. 1990;21:895-900. (Pubitemid 20209716)
5. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European cooperative acute stroke study (ECASS). JAMA. 1995;274:1017-25.
6. Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S. Recombinant tissue-type plasminogen activator (alteplase) for ischemic stroke 3 to 5 hours after symptom onset: the ATLANTIS study: A randomized controlled trial. JAMA. 1999;282:2019-26.
7. Acute Stroke Imaging Standardization Group-Japan. Procedure guidelines for acute stroke imaging 2007. Tokyo: Nankodo; 2007.
8. Ito H, Kanno I, Fukuda H. Human cerebral circulation: positron emission tomography studies. Ann Nucl Med. 2005;19:65-74. (Pubitemid 40745687)
9. 15O-labeled tracers. Ann Nucl Med. 2009;23:217-27.
10. Baron JC, Bousser MG, Rey A, Guillard A, Comar D, Castaigne P. Reversal of focal "misery-perfusion syndrome" by extra-intra-cranial arterial bypass in hemodynamic cerebral ischemia. A case study with 15O positron emission tomography. Stroke. 1981;12:454-9. (Pubitemid 11046690)
11. Powers WJ, Raichle ME. Positron emission tomography and its application to the study of cerebrovascular disease in man. Stroke. 1985;16:361-76. (Pubitemid 15034415)
12. Mohr JP, Barnett HJM. Classification of ischemic strokes. In: Barnett HJM, Stein BM, Mohr JP, Yatsu FM, editors. Stroke: pathophysiology, diagnosis, and management, vol. 1. New York: Churchill Livingston; 1986. p. 281-91.
13. Minematsu K, Yamaguchi T, Omae T. 'Spectacular shrinking deficit': rapid recovery from a major hemispheric syndrome by migration of an embolus. Neurology. 1992;42:157-62.
14. Olsen TS, Larsen B, Skriver EB, Herning M, Enevoldsen E, Lassen NA. Focal cerebral hyperemia in acute stroke. Incidence, pathophysiology and clinical significance. Stroke. 1981;12:598-607.
15. Marchal G, Young AR, Baron JC. Early postischemic hyperperfusion: pathophysiologic insights from positron emission tomography. J Cereb Blood Flow Metab. 1999;19:467-82. (Pubitemid 30159809)
16. Baird AE, Donnan GA, Austin MC, McKay WJ. Early reperfusion in the 'spectacular shrinking deficit' demonstrated by single-photon emission computed tomography. Neurology. 1995;45:1335-9.
17. Marchal G, Furlan M, Beaudouin V, Rioux P, Hauttement JL, Serrati C, et al. Early spontaneous hyperperfusion after stroke. A marker of favourable tissue outcome? Brain. 1996;119:409-19.
18. Garcia JH, Yoshida Y, Chen H, Li Y, Zhang ZG, Lian J, et al. Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat. Am J Pathol. 1993;142:623-35. (Pubitemid 23057474)
19. Powers WJ, Grubb RL, Darriet D, Raichle ME. Cerebral blood flow and cerebral metabolic rate of oxygen requirements for cerebral function and viability in humans. J Cereb Blood Flow Metab. 1985;5:600-8. (Pubitemid 16218236)
20. Higano S, Uemura K, Shishido F, Kanno I, Tomura N, Sakamoto K. Evaluation of critically perfused area in acute ischemic stroke for therapeutic reperfusion: a clinical PET study. Ann Nucl Med. 1993;7:167-71. (Pubitemid 23308857)
21. Astrup J, Siesjö BK, Symon L. Thresholds in cerebral ischemia - the ischemic penumbra. Stroke. 1981;12:723-5. (Pubitemid 12227362)
22. Jones TH, Morawetz RB, Crowell RM, Marcoux FW, FitzGibbon SJ, DeGirolami U, et al. Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg. 1981;54:773-82.
23. Doyle KP, Simon RP, Stenzel-Poore MP. Mechanisms of ischemic brain damage. Neuropharmacology. 2008;55:310-8.
24. Nag S, Manias JL, Stewart DJ. Pathology and new players in the pathogenesis of brain edema. Acta Neuropathol. 2009;118:197-217.
25. 99mTc-hexamethylpropyleneamine oxime in the early detection of cerebral infarction: comparison with transmission computed tomography. Nucl Med Commun. 1986;7:873-8.
26. Hill TC, Holman BL, Lovett R, O'Leary DH, Front D, Magistretti P, et al. Initial experience with SPECT (single-photon computerized tomography) of the brain using N-isopropyl I-123 p-iodoamphetamine: Concise communication. J Nucl Med. 1982;23:191-5. (Pubitemid 12185170)
27. Launes J, Nikkinen P, Lindroth L, Brownell AL, Liewendahl K, Livanainen M. Brain perfusion defect size in SPECT predicts outcome in cerebral infarction. Nucl Med Commun. 1989;10:891-900. (Pubitemid 20062183)
28. Watanabe Y, Takagi H, Aoki S, Sassa H. Prediction of cerebral infarct sizes by cerebral blood flow SPECT performed in the early acute stage. Ann Nucl Med. 1999;13:205-10. (Pubitemid 29461254)
29. Shimosegawa E, Hatazawa J, Inugami A, Fujita H, Ogawa T, Aizawa Y, et al. Cerebral infarction within six hours of onset: prediction of completed infarction with technetium-99m-HMPAO SPECT. J Nucl Med. 1994;35:1097-103. (Pubitemid 24204107)
30. Ueda T, Hatakeyama T, Kumon Y, Sakaki S, Uraoka T. Evaluation of risk of hemorrhagic transformation in local intraarterial thrombolysis in acute ischemic stroke by initial SPECT. Stroke. 1994;25:298-303. (Pubitemid 24047249)
31. Berrouschot J, Barthel H, Hesse S, Köster J, Knapp WH, Schneider D. Differentiation between transient ischemic attack and ischemic stroke within the first six hours after onset of symptoms by using 99mTc-ECD-SPECT. J Cereb Blood Flow Metab. 1998;18:921-9. (Pubitemid 28359911)
32. Ueda T, Sakaki S, Yuh WTC, Nochide I, Ohta S. Outcome in acute stroke with successful intra-arterial thrombolysis and predictive value of initial single-photon emission-computed tomography. J Cereb Blood Flow Metab. 1999;19:99-108. (Pubitemid 29283585)
33. 99mTc-ethyl cysteinate dimer single photon emission computed tomography. J Cereb Blood Flow Metab. 2000;20:1579-86.
34. Iseda T, Nakano S, Yano T, Suzuki Y, Wakisaka S. Time-threshold curve determined by single photon emission CT in patients with acute middle cerebral artery occlusion. AJNR Am J Neuroradiol. 2002;23:572-6. (Pubitemid 34411910)
35. Hirano T, Yonehara T, Inatomi Y, Hashimoto Y, Uchino M. Presence of early ischemic changes on computed tomography depends on severity and the duration of hypoperfusion. A single photon emission-computed tomographic study. Stroke. 2005;36:2601-8.
36. Gasparotti R, Grassi M, Mardighian D, Frigerio M, Pavia M, Liserre R, et al. Perfusion CT in patients with acute ischemic stroke treated with intra-arterial thrombolysis: predictive value of infarct core size on clinical outcome. AJNR Am J Neuroradiol. 2009;30:722-7.
37. Lansberg MG, Thijs VN, Bammer R, Olivot JM, Marks MP, Wechsler LR, et al. The MRA-DWI mismatch identifies patients with stroke who are likely to benefit from reperfusion. Stroke. 2008;39:2491-6.
38. Takasawa M, Jones PS, Guadagno JV, Christensen S, Fryer TD, Harding S, et al. How reliable is perfusion MR in acute stroke? Validation and determination of the penumbra threshold against quantitative PET. Stroke. 2008;39:870-7. (Pubitemid 351619576)
39. 2 without arterial sampling in hyperacute ischemic stroke: method and error analysis. Ann Nucl Med. 2004;18:35-44.
40. Kobayashi M, Okazawa H, Tsuchida T, Kawai K, Fujibayashi Y, Yonekura Y. Diagnosis of misery perfusion using noninvasive 15O gas PET. J Nucl Med. 2006;47:1581-6. (Pubitemid 47545021)
41. Kobayashi M, Kudo T, Tsujikawa T, Isozaki M, Arai Y, Fujibayashi Y, et al. Shorter examination method for the diagnosis of misery perfusion with count-based oxygen extraction fraction elevation in 15O-gas PET. J Nucl Med. 2008;49:242-6. (Pubitemid 351225662)
42. Olsen TS, Larsen B, Herning M, Skriver EB, Lassen NA. Blood flow and vascular reactivity in collaterally perfused brain tissue. Evidence of an ischemic penumbra in patients with acute stroke. Stroke. 1983;14:332-41. (Pubitemid 13100309)
43. Wise RJ, Bernardi S, Frackowiak RS, Legg NJ, Jones T. Serial observations on the pathophysiology of acute stroke. The transition from ischaemia to infarction as reflected in regional oxygen extraction. Brain. 1983;106:197-222. (Pubitemid 13152393)
44. Heiss WD, Huber M, Fink GR, Herholz K, Pietrzyk U, Wagner R, et al. Progressive derangement of periinfarct viable tissue in ischemic stroke. J Cereb Blood Flow Metab. 1992;12:193-203.
45. Hakim AM, Evans AC, Berger L, Kuwabara H, Worsley K, Marchal G, et al. The effect of nimodipine on the evolution of human cerebral infarction studied by PET. J Cereb Blood Flow Metab. 1989;9:523-34. (Pubitemid 19183299)
46. Heiss WD, Graf R, Wienhard K, Löttgen J, Saito R, Fujita T, et al. Dynamic penumbra demonstrated by sequential multitracer PET after middle cerebral artery occlusion in cats. J Cereb Blood Flow Metab. 1994;14:892-902. (Pubitemid 24332933)
47. Baron JC. Mapping of the ischaemic penumbra with PET: Implications for acute stroke treatment. Cerebrovasc Dis. 1999;9:193-201.
48. Furlan M, Marchal G, Viader F, Derlon JM, Baron JC. Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra. Ann Neurol. 1996;40:216-26. (Pubitemid 26274557)
49. Marchal G, Beaudouin V, Rioux P, de la Sayette V, Le Doze F, Viader F, et al. Prolonged persistence of substantial volumes of potentially viable brain tissue after stroke. A correlative PET-CT study with voxel-based data analysis. Stroke. 1996;27:599-606. (Pubitemid 26114416)
50. Hatazawa J, Shimosegawa E, Toyoshima H, Ardekani BA, Suzuki A, Okudera T, et al. Cerebral blood volume in acute brain infarction.Acombined study with dynamic susceptibility contrast MRI and 99mTc-HMPAO-SPECT. Stroke. 1999;30:800-6. (Pubitemid 29156371)
51. Mahagne MH, David O, Darcourt J, Migneco O, Dunac A, Chatel M, et al. Voxel-based mapping of cortical ischemic damage using Tc-99m L, L-ethyl cysteinate dimer SPECT in acute stroke. J Neuroimaging. 2004;14:23-32. (Pubitemid 37549674)
52. Marchal G, Benali K, Iglesias S, Viader F, Derlon JM, Baron JC. Voxel-based mapping of irreversible ischaemic damage with PET in acute stroke. Brain. 1999;122:2387-400.
53. B receptor-mediated responses in neocortex of rat and cat. J Physiol. 1988;406:443-68.
54. d'Argy R, Persson A, Sedvall G. A quantitative cerebral and whole body autoradiographic study of a intravenously administered benzodiazepine antagonist 3H-Ro 15-1788 in mice. Psychopharmacology. 1987;92:8-13. (Pubitemid 17063655)
55. Mazière M, Hantraye P, Kaijima M, Dodd R, Guibert B, Prenant C, et al. Visualization by positron emission tomography of apparent regional heterogeneity of central type benzodiazepine receptors in the brain of living baboons. Life Sci. 1985;36:1609-16. (Pubitemid 15095713)
56. Sette G, Baron JC, Young AR, Miyazawa H, Tillet I, Barré L, et al. In vivo mapping of brain benzodiazepine receptor changes by positron emission tomography after focal ischemia in the anesthetized baboon. Stroke. 1993;24:2046-57.
57. Schwartz RD, Yu X, Wagner J, Ehrmann M, Mileson BE. Cellular regulation of the benzodiazepine/GABA receptor: arachidonic acid, calcium, and cerebral ischemia. Neuropsychopharmacology. 1992;6:119-25.
58. Heiss WD, Grond M, Thiel A, Ghaemi M, Sobesky J, Rudolf J, et al. Permanent cortical damage detected by flumazenil positron emission tomography in acute stroke. Stroke. 1998;29:454-61. (Pubitemid 28086691)
59. Heiss WD, Kracht LW, Thiel A, Grond M, Pawlik G. Penumbral probability thresholds of cortical flumazenil binding and blood flow predicting tissue outcome in patients with cerebral ischaemia. Brain. 2001;124:20-9. (Pubitemid 32055986)
60. Guadagno JV, Jones PS, Aigbirhio FI, Wang D, Fryer TD, Day DJ, et al. Selective neuronal loss in rescued penumbra relates to hypoperfusion. Brain. 2008;131:2666-78.
61. Hatazawa J, Satoh T, Shimosegawa E, Okudera T, Inugami A, Ogawa T, et al. Evaluation of cerebral infarction with iodine 123-iomazenil SPECT. J Nucl Med. 1995;36:2154-61.
62. Nakagawara J, Sperling B, Lassen NA. Incomplete brain infarction of reperfused cortex may be quantitated with iomazenil. Stroke. 1997;28:124-32.
63. Dong Y, Fukuyama H, Nabatame H, Yamauchi H, Shibasaki H, Yonekura Y. Assessment of benzodiazepine receptors using iodine-123-labeled iomazenil single-photon emission computed tomography in patients with ischemic cerebrovascular disease. A comparison with PET study. Stroke. 1997;28:1776-82. (Pubitemid 27391449)
64. Saur D, Buchert R, Knab R, Weiller C, Rö ther J. Iomazenil-single-photon emission computed tomography reveals selective neuronal loss in magnetic resonance-defined mismatch areas. Stroke. 2006;37:2713-9. (Pubitemid 44922531)
65. Chapman JD, Baer K, Lee J. Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells. Cancer Res. 1983;43:1523-8. (Pubitemid 13122542)
66. 3H]misonidazole in cerebral ischemia. Stroke. 1987;18:168-76.
67. Mathias CJ, Welch MJ, Kilbourn MR, Jerabek PA, Patrick TB, Raichle ME, et al. Radiolabeled hypoxic cell sensitizers: tracers for assessment of ischemia. Life Sci. 1987;41:199-206. (Pubitemid 17089129)
68. Read SJ, Hirano T, Abbott DF, Sachinidis JI, Tochon-Danguy HJ, Chan JG, et al. Identifying hypoxic tissue after acute ischemic stroke using PET and 18F-fluoromisonidazole. Neurology. 1998;51:1617-21.
69. Read SJ, Hirano T, Abbott DF, Markus R, Sachinidis JI, Tochon-Danguy HJ, et al. The fate of hypoxic tissue on 18F-fluoromisonidazole positron emission tomography after ischemic stroke. Ann Neurol. 2000;48:228-35. (Pubitemid 30617042)
70. Markus R, Reutens DC, Kazui S, Read S, Wright P, Chambers BR, et al. Topography and temporal evolution of hypoxic viable tissue identified by 18F-fluoromisonidazole positron emission tomography in humans after ischemic stroke. Stroke. 2003;34:2646-52. (Pubitemid 37392759)
71. Spratt NJ, Ackerman U, Tochon-Danguy HJ, Donnan GA, Howells DW. Characterization of fluoromisonidazole binding in stroke. Stroke. 2006;37:1862-7. (Pubitemid 44297743)
72. 99mTc HMPAO SPECT. J Neurol Neurosurg Psychiatry. 1998;64:90-7.
73. Oku N, Matsumoto M, Hashikawa K, Moriwaki H, Ishida M, Seike Y, et al. Intra-individual differences between technetium-99m-HMPAO and technetium-99m-ECD in the normal medial temporal lobe. J Nucl Med. 1997;38:1109-11. (Pubitemid 27339619)
74. Asenbaum S, Brücke T, Pirker W, Pietrzyk U, Podreka I. Imaging of cerebral blood flow with technetium-99m-HMPAO and technetium-99m-ECD: a comparison. J Nucl Med. 1998;39:613-8. (Pubitemid 28175833)
75. Sperling B, Lassen NA. Hyperfixation of HMPAO in subacute ischemic stroke leading to spuriously high estimates of cerebral blood flow by SPECT. Stroke. 1993;24:193-4. (Pubitemid 23043454)
76. 99mTc-HMPAO brain SPECT in subacute stroke. Ann Nucl Med. 2000;14:159-63.
77. 99mTc-HMPAO retention in nervous tissue: in vivo study. J Nucl Med. 1999;40:1556-62.
78. Fujibayashi Y, Taniuchi H, Waki A, Yokoyama A, Ishii Y, Yonekura Y. Intracellular metabolism of 99mTc-d, l-HMPAO in vitro: a basic approach for understanding the hyperfixation mechanism in damaged brain. Nucl Med Biol. 1998;25:375-8. (Pubitemid 28219101)
79. Yamada N, Imakita S, Sakuma T. Value of diffusion-weighted imaging and apparent diffusion coefficient in recent cerebral infarctions: a correlative study with contrast-enhanced T1-weighted imaging. AJNR Am J Neuroradiol. 1999;20:193-8. (Pubitemid 30418697)
80. 99mTc-bicisate (ECD, neurolite) measured by SPECT on same day. J Cereb Blood Flow Metab. 1994;Suppl 1:S44-8.
81. Tsuchida T, Nishizawa S, Yonekura Y, Sadato N, Iwasaki Y, Fujita T, et al. SPECT images of technetium-99m-ethyl cysteinate dimer in cerebrovascular diseases: comparison with other cerebral perfusion tracers and PET. J Nucl Med. 1994;35:27-31. (Pubitemid 24018436)
82. 99mTc-bicisate single-photon emission tomography in the demonstration of focal hyperemia during the subacute phase of an ischaemic stroke. Eur J Nucl Med. 1994;21:254-7.
83. 99mTc-HMPAO imaging. Ann Nucl Med. 1995;9:161-6.
84. 133Xe SPECT. J Nucl Med. 2001;42:543-7.
85. 99mTc-ECD). J Cereb Blood Flow Metab. 1994;Suppl 1:S4-11.
86. 99mTc-ethylcysteinate dimer in infarcted brain tissue of rats. J Nucl Med. 2001;42:802-7.
87. Block M, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci. 2007;8:57-69. (Pubitemid 46011999)
88. Hanisch UK, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci. 2007;10:1387-94. (Pubitemid 350014685)
89. Neumann H, Kotter MR, Franklin RJ. Debris clearance by microglia: an essential link between degeneration and regeneration. Brain. 2009;132:288-95.
90. Benavides J, Cornu P, Dennis T, Dubois A, Hauw JJ, MacKenzie ET, et al. Imaging of human brain lesions with an omega 3 site radioligand. Ann Neurol. 1988;24:708-12. (Pubitemid 19019023)
91. 11C]PK11195 and positron emission tomography in patients after ischemic stroke. Neuroreport. 2000;11:2957-60.
92. Gerhard A, Schwarz J, Myers R, Wise R, Banati RB. Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study. Neuroimage. 2005;24:591-5. (Pubitemid 41359057)
93. Price CJ, Wang D, Menon DK, Guadagno JV, Cleij M, Fryer T, et al. Intrinsic activated microglia map to the peri-infarct zone in the subacute phase of ischemic stroke. Stroke. 2006;37:1749-53. (Pubitemid 44297724)
94. 11C]PK11195 by PET and induction of the peripheral-type benzodiazepine receptor after transient focal ischemia in rats. J Cereb Blood Flow Metab. 2007;27:1975-86.
95. 18F]FDG-PET study. J Cereb Blood Flow Metab. 2009;29:1216-25.
96. Radlinska BA, Ghinani SA, Lyon P, Jolly D, Soucy JP, Minuk J, et al. Multimodal microglia imaging of fiber tracts in acute subcortical stroke. Ann Neurol. 2009;66:825-32.
97. Yuan J. Neuroprotective strategies targeting apoptotic and necrotic cell death for stroke. Apoptosis. 2009;14:469-77.
98. Broughton BR, Reutens DC, Soby CG. Apoptotoic mechanisms after cerebral ischemia. Stroke. 2009;40:e331-9.
99. Seigneuret M, Devaux PF. ATP-dependent asymmetric distribution of spin-labeled phospholipids in the erythrocyte membrane: relation to shape changes. Proc Natl Acad Sci USA. 1984;81:3751-5. (Pubitemid 14087796)
100. Diaz C, Schroit AJ. Role of translocases in the generation of phosphatidylserine asymmetry. J Membr Biol. 1996;151:1-9. (Pubitemid 26164252)
101. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol. 1992;148:2207-16.
102. Andree HA, Reutelingsperger CP, Hauptmann R, Hemker HC, Hermens WT, Willems GM. Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J Biol Chem. 1990;265:4923-8.
103. Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC, LaFace DM, et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med. 1995;182:1545-56.
104. 99mTc-HYNIC-annexin V SPECT imaging of acute stroke and its response to neuroprotective therapy with anti-Fas ligand antibody. Eur J Nucl Med Mol Imaging. 2006;33:566-74.
105. Lorberboym M, Blankenberg FG, Sadeh M, Lampl Y. In vivo imaging of apoptosis in patients with acute stroke: correlation with blood-brain barrier permeability. Brain Res. 2006;1103:13-9. (Pubitemid 44080115)